机构

• 上海药物研究所 [46]
• 长春应用化学研究所 [10]
• 过程工程研究所 [8]
• 合肥物质科学研究院 [6]
• 宁波材料技术与工程研... [5]
• 化学研究所 [5]
• 更多

采集方式

• OAI收割 [96]
• iSwitch采集 [3]

内容类型

• 期刊论文 [99]

发表日期

• 3111 [1]
• 2024 [6]
• 2023 [6]
• 2022 [9]
• 2021 [11]
• 2020 [9]
• 更多

学科主题

• Materials ... [3]
• Cell Biolo... [2]
• Research &... [2]
• Science & ... [2]
• Chemistry [1]
• Endocrinol... [1]
• 更多

筛选

浏览/检索结果: 共99条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21 (CIP1/WAF1) in human cancer cells1 期刊论文  OAI收割 出版物, 3111, 期号: 0, 页码: 1-35 作者:  Jingru Li;  Yicheng Chen;  Jiali Wan;  Xin Liu;  Chunrong Yu   |  收藏  |  浏览/下载：262/0  |  提交时间：2017/07/24 Abt-263  Sorafenib  Combination Therapy  Cancer   Advancements and challenges in immunocytokines: A new arsenal against cancer 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2024, 卷号: 14, 期号: 11, 页码: 4649-4664 作者:  Shi, Wenqiang;  Liu, Nan;  Lu, Huili   |  收藏  |  浏览/下载：8/0  |  提交时间：2024/12/25 Bifunctional fusion  Combination therapy  Tumor-conditional  Prodrug   Resveratrol enhances the antiliver cancer effect of cisplatin by targeting the cell membrane protein PLA2 期刊论文  OAI收割 FRONTIERS IN ONCOLOGY, 2024, 卷号: 14 作者:  Gao, Yu;  Yang, Zhanyi;  Bajpai, Akhilesh Kumar;  Wang, Wenben;  Zhang, Liyuan   |  收藏  |  浏览/下载：3/0  |  提交时间：2024/11/20 combination therapy  resveratrol  cisplatin  anti-liver cancer mechanism  cell membrane  PLA2   The combination of methionine adenosyltransferase 2A inhibitor and methyltransferase like 3 inhibitor promotes apoptosis of non-small cell lung cancer cells and produces synergistic anti-tumor activity 期刊论文  OAI收割 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 卷号: 716, 页码: 12 作者:     |  收藏  |  浏览/下载：12/0  |  提交时间：2024/07/12 MAT2A inhibitor  METTL3 inhibitor  m6A  Combination therapy  NSCLC   Co-inhibition of BET and NAE enhances BIM-dependent apoptosis with augmented cancer therapeutic efficacy 期刊论文  OAI收割 BIOCHEMICAL PHARMACOLOGY, 2024, 卷号: 223, 页码: 17 作者:  Zhang, Qian;  Wu, Qian;  Huan, Xia-Juan;  Song, Shan -Shan;  Bao, Xu-Bin   |  收藏  |  浏览/下载：24/0  |  提交时间：2024/06/27 BET inhibitor  NAE inhibitor  BIM  Apoptosis  Combination therapy   Tumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 12 作者:  Zou, Zhi-feng;  Yang, Lei;  Nie, Hui-jun;  Gao, Jing;  Lei, Shu-min   |  收藏  |  浏览/下载：16/0  |  提交时间：2024/05/22 proteolysis-targeting chimeras  tumor-targeted delivery  precise protein degradation  combination therapy  triple-negative breast cancer   The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors 期刊论文  OAI收割 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 卷号: 17, 期号: 1, 页码: 32 作者:  Wei, Qing;  Li, Peijing;  Yang, Teng;  Zhu, Jiayu;  Sun, Lu   |  收藏  |  浏览/下载：56/0  |  提交时间：2024/02/27 Antibody-drug conjugate  Solid tumor  Combination therapy  Immunotherapy  Targeted therapy   Epigenetic-based combination therapy and liposomal codelivery overcomes osimertinib-resistant NSCLC via repolarizing tumor-associated macrophages 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2023, 页码: 12 作者:  Lin, Ting-ting;  Xiong, Wei;  Chen, Gui-hua;  He, Yang;  Long, Li   |  收藏  |  浏览/下载：17/0  |  提交时间：2024/01/26 osimertinib resistance  targeted drug delivery  liposomes  panobinostat  tumor-associated macrophage  combination therapy   From bench to bedside: current development and emerging trend of KRAS-targeted therapy 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2023, 页码: 18 作者:  Chen, Yi;  Liu, Qiu-pei;  Xie, Hua;  Ding, Jian   |  收藏  |  浏览/下载：54/0  |  提交时间：2024/01/16 KRAS mutation  KRAS(G12C) inhibitor  Pan-KRAS inhibitor  SHP2 allosteric inhibitor  SOS1 inhibitor  combination therapy   Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 6, 页码: 2601-2612 作者:  Wang, Xiaomin;  Xu, Jun;  Sun, Yiming;  Cao, Siyuwei;  Zeng, Hanlin   |  收藏  |  浏览/下载：44/0  |  提交时间：2023/10/17 HDAC inhibitors  Drug resistance  Histone methylation  Histone acetylation  Epigenetic interplay  Hedgehog pathway  ZIC1  LIFR  Combination therapy  Breast cancer